Acadia Pharmaceuticals Inc. Share Price
NASDAQ: ACADHealthcare
Live Acadia Pharmaceuticals Inc. Share Price Chart
O H L
Acadia Pharmaceuticals Inc. Performance Overview
Days Range
▼
$27.15Low
$27.44High
Markets Today
| Previous Close | $27.45 |
|---|---|
| Open | $27.37 |
| Volume | 169,152 |
| Day's Range | $27.15 - $27.44 |
| 52W Range | $19.69 - $30.96 |
| Market Cap | $4.75 B |
Historical Performance
| 1M Returns | -9.05 |
|---|---|
| 3M Returns | +26.97 |
| 6M Returns | +35.09 |
| 1Y Returns | +10.89 |
| 5Y Returns | +64.37 |
| 10Y Returns | -21.17 |
Acadia Pharmaceuticals Inc. Fundamentals
| Market Cap | $4.75 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 12.45 |
| PEG Ratio | N/A |
| Revenue | $1.07 B |
| ROE TTM | 0.40 |
| EPS TTM | $2.21 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.63 |
| EBITDA | $116.57 M |
| Profit Margin | 36.49 |
| Market Cap | $4.75 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 12.45 |
| PEG Ratio | N/A |
| Revenue | $1.07 B |
| ROE TTM | 0.40 |
| EPS TTM | $2.21 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.63 |
| EBITDA | $116.57 M |
| Profit Margin | 36.49 |
Acadia Pharmaceuticals Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $244.32 M | $264.57 M | $278.63 M | $283.99 M | $268.06 M | $307.96 M |
| Gross Profit + | $223.93 M | $243.83 M | $256.99 M | $257.76 M | $243.27 M | $279.64 M |
| Operating Income | $19.29 M | $32.37 M | $35.76 M | $17.39 M | -$4.62 M | $37.84 M |
| EBITDA | $22.24 M | $29.86 M | $38.71 M | $20.32 M | -$1.62 M | $35.55 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $2.95 M | -$2.51 M | $2.95 M | $2.92 M | $2.99 M | -$2.29 M |
| Income Before Tax | $27.78 M | $40.21 M | $44.59 M | $26.32 M | $3.98 M | $46.47 M |
| Income Tax Expense | $8.79 M | $13.54 M | -$27.18 M | -$247.25 M | $344.00 K | $14.97 M |
| Net Income + | $18.99 M | $26.67 M | $71.78 M | $273.57 M | $3.64 M | $31.50 M |
| Net Profit Margin | 7.77% | 10.08% | 25.76% | 96.33% | 1.36% | 10.23% |
Acadia Pharmaceuticals Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $16.00 K | $16.00 K | $16.00 K | $16.00 K | $16.00 K | $16.00 K |
| Reserve & Surplus | -$2.18 B | -$2.16 B | -$2.09 B | -$1.81 B | -$1.81 B | -$1.78 B |
| Non-Current Liabilities | $64.60 M | $73.15 M | $56.91 M | $59.69 M | $51.64 M | $74.86 M |
| Current Liabilities | $302.53 M | $330.02 M | $356.58 M | $277.11 M | $305.52 M | $361.44 M |
| Total Liabilities | $367.13 M | $403.17 M | $413.50 M | $336.81 M | $357.16 M | $436.29 M |
| Fixed Assets | $120.56 M | $117.89 M | $115.32 M | $116.40 M | $120.82 M | $120.56 M |
| Current Assets | $870.94 M | $960.55 M | $1.08 B | $1.06 B | $1.10 B | $1.22 B |
| Total Assets | $1.13 B | $1.23 B | $1.33 B | $1.56 B | $1.61 B | $1.74 B |
Acadia Pharmaceuticals Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $18.99 M | $26.67 M | $71.78 M | $273.57 M | $3.64 M | $31.50 M |
| Operating Cash Flow | $20.32 M | $63.96 M | $74.29 M | -$48.73 M | $33.98 M | $100.78 M |
| Investing Cash Flow | -$124.05 M | -$43.29 M | -$79.35 M | -$55.87 M | $66.28 M | -$8.53 M |
| Financing Cash Flow | $1.84 M | $15.96 M | $9.42 M | $22.67 M | $4.23 M | $10.49 M |
| Change in Cash | -$101.89 M | $36.64 M | $4.36 M | -$81.93 M | $104.52 M | $102.77 M |
Acadia Pharmaceuticals Inc. Return Calculator
The Acadia Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$16,281
Invested Amount$10,000
Est. Returns$6,281
About Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world. It has two core franchises in neurological and rare diseases. Its neurological disease is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. (FDA) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.
Popular Stocks
FAQs
What is the share price of Acadia Pharmaceuticals Inc. today?
Acadia Pharmaceuticals Inc. (ACAD) share price as of September 18, 2026 is $27.19. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Acadia Pharmaceuticals Inc.?
Yes, Indian Investors can invest in the Acadia Pharmaceuticals Inc. (ACAD) Share by opening an international trading account with Angel One.
How can I purchase Acadia Pharmaceuticals Inc. shares in India?
Purchasing Acadia Pharmaceuticals Inc. (ACAD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Acadia Pharmaceuticals Inc. (ACAD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Acadia Pharmaceuticals Inc.?
Yes, you can purchase fractional shares of Acadia Pharmaceuticals Inc. (ACAD) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Acadia Pharmaceuticals Inc.?
The market capitalization of Acadia Pharmaceuticals Inc. on September 18, 2026, is $4.75 B.
In which sector Acadia Pharmaceuticals Inc. belongs?
Acadia Pharmaceuticals Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Acadia Pharmaceuticals Inc. stocks?
In order to invest in Acadia Pharmaceuticals Inc. (ACAD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
